Targeted Intervention to Improve Medication Adherence in Cognitively Impaired Patients With HF (TARGET) (TARGET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01602731
Recruitment Status : Completed
First Posted : May 21, 2012
Results First Posted : November 6, 2015
Last Update Posted : November 6, 2015
Information provided by (Responsible Party):
VA Office of Research and Development

Brief Summary:
Trialing an automated medication dispensing device (AMDD) to improve medication adherence in patients with heart failure.

Condition or disease Intervention/treatment Phase
Heart Failure Device: Automated Medication Dispensing Device Not Applicable

Detailed Description:


Medication adherence [MA] is a complex issue depending on both patient and healthcare factors. Non-adherence due to patient-dependent factors is common; analyses of large broad-based clinical trials in the general population demonstrate that 20-30% of study medication doses may be missed. In community-dwelling HF patients with polypharmacy this percentage is likely even higher. One of the factors in poor adherence in elderly non-HF patients has been shown to be cognitive impairment [CI]. Non-adherence to medical regimen is one factor that is associated with worse outcomes in patients with HF, including readmissions. Measures that improve MA are also likely to improve outcomes.


We evaluated a novel intervention incorporating new technology with the goal of improving adherence in patients with HF and CI. Specific objectives of the study were (1) to assess the feasibility of using the Automated Medication Dispensing Device (AMDD) in veterans with HF and CI by measuring patient qualifying rate, consent rate, user rate, patient-level response rate, medication-level response rate, and success rate, (2) to calculate the improvement of MA based on pill counts before and after the introduction of the AMDD, and (3) qualitatively describe patient satisfaction with the AMDD and the reasons for not using the AMDD.


This pilot was designed as a feasibility study testing an intervention using a commercially available, off the shelf Automated Medication Dispensing Device (AMDD) with subjects serving as their own controls. The study was conducted at the VALLHS, Loma Linda, CA which serves a population of 246,000 veterans. The study planned to enroll 50 patients with HF and CI (defined as SLUMS score of <27 in a person with high school education or <25 in a person with less than high school education) from the outpatient HF clinic. Baseline adherence to prescribed medications was measured by an initial 30-day pill count (month 1). Subjects with baseline adherence <88% were given the AMDD to use for 90 days (one month to familiarize the study subjects with the device, two months to collect outcome data). This dispenser was pre-filled by home health nurses once a month; the dispenser is equipped with an alarm mechanism that alerts the patient to take the medications; when the patient pushes the button on the device, it will dispense the medications. 30-day pill counts were performed while patients were using the AMDD on months 3 and 4. The study was powered to detect the success rate of the AMDD, defined as both patient acceptance and a clinical response to the AMDD.


Complete. This project was opened for recruitment as of July 1, 2012. The study is now closed for recruitment and all enrolled patients have completed the intervention. Manuscript outlining the findings of this study and discussing the available interventions to improve medication adherence is in progress.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 45 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Targeted Intervention to Improve Medication Adherence in Cognitively Impaired Patients With Heart Failure
Study Start Date : October 2012
Actual Primary Completion Date : February 2014
Actual Study Completion Date : February 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Failure

Arm Intervention/treatment
Experimental: Automated Medication Dispensing Device
Subjects with <88% medication adherence, determined by 30-day pillcount, and with cognitive impairment (determined by Saint Louis University Mental Status score) proceeded to AMDD portion of study.
Device: Automated Medication Dispensing Device
All patients had a pre-filled medication dispensing machine set up at their homes, filled by home health nurses once a month. Safety phone call was made by the AMDD company if doses were missed.
Other Name: AMDD

Primary Outcome Measures :
  1. Feasibility of AMDD to Improve Medication Adherence Via Completion Rate [ Time Frame: 4 months ]
    Rate that patient population completed set-up of AMDD was evaluated quantitatively.

Secondary Outcome Measures :
  1. Efficacy of AMDD to Improve Medication Adherence [ Time Frame: 30-day pill count before the use of AMDD and with AMDD ]
    Change in medication adherence (proportion of pills taken of prescribed, as measured by pillcount) after the implementation of the AMDD

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients with established diagnosis of clinical heart failure
  • English-speaking
  • Able to provide informed consent
  • Able to participate in cognitive function testing
  • Age over 18

Exclusion Criteria:

  • Life expectancy < 6 months
  • Documented dementia requiring a caregiver
  • inability to set up the AMDD at the patient's home due to technical limitations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01602731

United States, California
VA Medical Center, Loma Linda
Loma Linda, California, United States, 92357
Sponsors and Collaborators
VA Office of Research and Development
Principal Investigator: Helme Silvet, MD VA Medical Center, Loma Linda

Responsible Party: VA Office of Research and Development Identifier: NCT01602731     History of Changes
Other Study ID Numbers: RRP 12-198
First Posted: May 21, 2012    Key Record Dates
Results First Posted: November 6, 2015
Last Update Posted: November 6, 2015
Last Verified: October 2015

Keywords provided by VA Office of Research and Development:
medication adherence

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases